Home  >  Products  >  NAPSA (napsin A aspartic peptidase ) Blocking Peptide (the C terminal of NAPSA)(100ug)
NAPSA (napsin A aspartic peptidase ) Blocking Peptide (the C terminal of NAPSA)(100ug)

NAPSA (napsin A aspartic peptidase ) Blocking Peptide (the C terminal of NAPSA)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NAPSA Antibody (ARP64546_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64546
Size: 100ug
Weight: 39kDa
Gene: 9476
Format: Lyophilized powder
Target: The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
Alternative names: KAP; Kdap; NAP1; NAPA; SNAPA
See Full Product Listings >